Research

Hormonal

Tirzepatide can cause direct drug-induced liver injury (hepatitis) independent of gallbladder disease, characterized by elevated liver enzymes and bilirubin that normalize upon discontinuation.

If you are taking Tirzepatide and experience symptoms like jaundice, dark urine, or right-sided abdominal pain, seek medical attention immediately. Your doctor should check liver enzymes. If levels are elevated, stopping the drug typically leads to full recovery within a month, but this requires prompt medical intervention and monitoring.

LimitedSupportsLOW confidence
This made us consider the possibility of tirzepatide causing direct hepatocyte damage rather than the previously known hepatocyte injury as a consequence of gallbladder disease... We calculated the RUCAM... score, which came to be 7, suggesting that tirzepatide is a probable cause of hepatotoxicity in this case.
Rayan Tareg Ahmed et al. · Annals of Internal Medicine Clinical Cases · 2025

Why this rating

Based on a single case report (n=1) and one other cited case; lacks controlled trial data.

Source

A Rare Case of Tirzepatide-Induced Hepatitis: Causality Assessment With the RUCAM Criteria

Rayan Tareg Ahmed et al. · Annals of Internal Medicine Clinical Cases · 2025

DOI 10.7326/aimcc.2024.0923

case_report · n=1Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →